Atlas Trials

Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study

Clinical trial NCT02096965 · COMPLETED

Trial details

NCT number
NCT02096965
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Nephrolithiasis, Calcium OxalateNephrolithiasis, Calcium Phosphate
Start date
2014-03-01
Primary completion
2015-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.